CD36 and metastatic malignant neoplasm in the lymph nodes: CD36 could be used in the future for risk stratification concerning lymph node metastasis and might guide surgeons in the decision-making process of the necessity of cervical lymph node dissection, especially if there is uncertainty whether a cervical lymph node dissection is indicated.